Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-06 Option Award |
2025-02-10 5:34 pm |
N/A 2035-02-06 |
Enliven Therapeutics Inc. | ELVN | Bauer Jake Director |
20,491 | $0 | 20,491 (Direct) |
View |
| 2024-02-13 Option Award(A) |
2024-02-20 7:26 pm |
N/A 2034-02-13 |
Enliven Therapeutics Inc. | ELVN | Bauer Jake Director |
23,364 | $0 | 23,364 (Direct) |
View |
| 2024-02-13 Option Award |
2024-02-15 8:44 pm |
N/A 2034-02-12 |
Enliven Therapeutics Inc. | ELVN | Bauer Jake Director |
16,835 | $0 | 16,835 (Direct) |
View |
| 2023-02-23 Option Award |
2023-04-06 8:16 pm |
N/A 2033-02-23 |
Enliven Therapeutics Inc. | ELVN | Bauer Jake Director |
27,567 | $0 | 27,567 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-27 9:51 pm |
N/A 2032-08-12 |
Enliven Therapeutics Inc. | ELVN | Bauer Jake Director |
105,078 | $0 | 105,078 (Direct) |
View |
Ownership |
2021-07-12 7:54 pm |
N/A N/A |
ARYA Sciences Acquisition Corp V | ARYE | Bauer Jake Director |
0 | $0 | 30,000 (Direct) |
View |
| 2020-11-17 Equity Swap |
2020-11-19 8:19 pm |
N/A N/A |
MyoKardia Inc. | MYOK | Bauer Jake Chief Business Officer |
90,209 | $0 | 0 (Direct) |
View |
Ownership |
2020-06-04 9:44 pm |
N/A N/A |
ARYA Sciences Acquisition Corp II | ARYB | Bauer Jake Director |
0 | $0 | 30,000 (Direct) |
View |
| 2020-04-30 Option Award |
2020-06-04 4:20 pm |
N/A N/A |
MyoKardia Inc. | MYOK | Bauer Jake Chief Business Officer |
293 | $50.41 | 57,784 (Direct) |
View |